Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ambicin antimicrobial data

AMBI (Brooklyn) said it obtained positive data on its antimicrobial product from three

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE